Remove tag patient-communities
article thumbnail

Grand Rounds September 22, 2023: Integrating Community Health Workers into Team-Based, Early Childhood Preventative Care (Tumaini Rucker Coker, MD, MBA)

Rethinking Clinical Trials

Adapted for early childhood preventive care, the structure should be team- and community-based. The PARENT group added interventions such as a community health worker “parent coach,” a pre-visit tool to help identify parent priorities, a text message service to keep in touch between visits, and a brief, focused clinician visit.

Trials 271
article thumbnail

Grand Rounds June 16, 2023: BeatPain Utah: Partnering With Community Health Centers Within a Socio-Technical Framework (Julie Fritz, PT, PhD, FAPTA; Guilherme Del Fiol, MD, PhD)

Rethinking Clinical Trials

However, persons in low-income and rural communities have significantly higher odds of receiving a prescription opioid for a new back pain diagnosis. Many of these communities are served by federally qualified health centers that often lack options to provide accessible nonpharmacologic alternatives.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds January 12, 2024: Design and Implementation of a Weighted Lottery to Equitably Allocate Scarce Covid-19 Resources (Erin K. McCreary, PharmD, BCIDP)

Rethinking Clinical Trials

UPMC did not allow patients to receive experimental COVID-19 therapies outside of the context of a clinical trial and used the REMAP-CAP platform, a global pragmatic adaptive trial platform, in all clinic sites. Every patient with COVID-19 was automatically considered. Patients were screened by local teams at each site.

article thumbnail

Grand Rounds August 19, 2022: Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change (Gerald Bloomfield, MD, MPH; Michelle Kelsey, MD)

Rethinking Clinical Trials

Participating organizations included FDA, NIH, academic institutions, pharmaceutical and device companies, patient advocacy groups, community groups, and data groups, and representatives from each organization had opportunity to extend invitation to others. Ask and engage community partners. Learn more. pctGR, @Collaboratory1.

article thumbnail

What is Biogen and can they repair their reputation?

World of DTC Marketing

This drug was never about patients; it was about a company whose ego got too big and needed a savior in the form of a medicine that could bring in hundreds of millions of dollars. Many doctors also became upset at the idea of telling Alzheimer’s patients that the drug didn’t work. Biogen is in trouble.

Drugs 222
article thumbnail

Grand Rounds Ethics and Regulatory Series November 11, 2022: Data Sharing and Pragmatic Clinical Trials: Law & Ethics Amidst a Changing Policy Landscape (Stephanie Morain, PhD, MPH; Kayte Spector-Bagdady, JD, MBioethics)

Rethinking Clinical Trials

But if PCTs use a waiver/alteration of consent, the trial cannot assume sharing data is consistent with preferences of patient-subjects and cannot rely on informed consent to fulfill the ethical obligation of respect. For PCTs, data volume is potentially larger, data may be “about” those beyond patient-subjects (i.e.

article thumbnail

Grand Rounds February 9, 2024: Pragmatic Recruitment of Underrepresented Groups – Experience From the Diuretic Comparison Project (Cynthia Hau, MPH)

Rethinking Clinical Trials

It had a pragmatic recruitment model with an embedded design, multicenter study without local study investigators and management teams, and broad recruitment that included patients from all 50 states and Puerto Rico. At the time, more than 95% of VA patients received hydrochlorothiazide for thiazide-type diuretic.